phenotypeId,phenotypeName,referentConceptId,clinicalDescription,literatureReview,phenotypeNotes
192675000,Biliary cirrhosis,192675,Overview: a disease of immune system with T-cell mediated attack on intralobular hepatic bile ducts. Presentation: Patients may be asymptomatic or may have signs and symptoms of cholestasis like fatigue to pruritus.Assessment: liver enzyme with alkaline phosphatase elevation. antimitochondrial antibodies (AMA) is considered serologic hallmark.Plan: symptom management. Disease progression may be slowed with ursodeoxycholic acid.Prognosis: long term disease that may progress with portal hypertension and/or hepatocellular carcinoma.,NA,NA
